• Diagnosis​ ​Info​ ​and​ ​General​ ​Questions

  For LGMD 2E, Myonexus’ MYO-101 Given Rare Pediatric Disease Status

  Posted by MD forums Moderator on April 7, 2019 at 1:07 pm

  The FDA granted rare pediatric disease status to Myonexus Therapeutics’ experimental gene therapy MYO-101 for limb girdle muscular dystrophy type 2E. Find out more about this therapy here.

  What are your thoughts on this news?

  replied 6 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply